BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15549692)

  • 1. The FocalPoint System: FocalPoint slide profiler and FocalPoint GS.
    Kardos TF
    Cancer; 2004 Dec; 102(6):334-9. PubMed ID: 15549692
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
    Wilgenbusch H; Mueller G; Neal M; Renshaw AA
    Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FocalPoint slide classification algorithms show robust performance in classification of high-grade lesions on SurePath liquid-based cervical cytology slides.
    Parker EM; Foti JA; Wilbur DC
    Diagn Cytopathol; 2004 Feb; 30(2):107-10. PubMed ID: 14755762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to take cervical smears.
    Johnson W
    Community Nurse; 1999 Jun; 5(5):27-30. PubMed ID: 10513548
    [No Abstract]   [Full Text] [Related]  

  • 5. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 7. Calibration of the Becton Dickinson FocalPoint GS slide profiler is essential for optimal performance: Avoiding the algorithm supersaturation cascade effect pitfall.
    Nuttall DS; Anderson WJ; Savage AJ; Denton K; Martin CM; O'Leary JJ
    Cancer Cytopathol; 2023 Jun; 131(6):383-391. PubMed ID: 36973942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automation in cervical cancer screening. Part 1: fixed cell scanning systems.
    Husain OA; Tucker JH; Roberts BA
    Biomed Eng; 1976 May; 11(5):161-6. PubMed ID: 945084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
    Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
    Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public expectations, achievable cervical screening sensitivity, and the standard of practice.
    Austin RM
    Cancer; 2003 Feb; 99(1):1-3. PubMed ID: 12589638
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality assessment in the age of machine-aided cervical cytology screening.
    Renshaw AA
    Cancer; 2004 Dec; 102(6):345-7. PubMed ID: 15540251
    [No Abstract]   [Full Text] [Related]  

  • 12. Practice tips. Smear tactics: a more comfortable Papanicolaou test.
    Tsang N; Osmun WE
    Can Fam Physician; 2007 May; 53(5):835. PubMed ID: 17872746
    [No Abstract]   [Full Text] [Related]  

  • 13. Colposcopy, cervical screening, and HPV. Preface.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
    [No Abstract]   [Full Text] [Related]  

  • 14. New cervical cancer screening techniques.
    McNeeley SG
    Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S40-1. PubMed ID: 14586319
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality control in cervical cancer screening: Brazilian experience.
    Collaço LM; de Noronha L; Bleggi-Torres LF; Pinheiro DL
    Acta Cytol; 2005; 49(6):694-6. PubMed ID: 16450916
    [No Abstract]   [Full Text] [Related]  

  • 16. Can we change the way we screen?: the ThinPrep Imaging System.
    Dawson AE
    Cancer; 2004 Dec; 102(6):340-4. PubMed ID: 15540250
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology.
    Arbyn M; Herbert A; Schenck U; Nieminen P; Jordan J; Mcgoogan E; Patnick J; Bergeron C; Baldauf JJ; Klinkhamer P; Bulten J; Martin-Hirsch P
    Cytopathology; 2007 Jun; 18(3):133-9. PubMed ID: 17573762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automation of primary screening for cervical cancer. Sooner or later?
    Bartels PH; Vooijs GP
    Acta Cytol; 1999; 43(1):7-12. PubMed ID: 9987443
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Liquid-based cytology for cervical screening.
    Blamey S; Jackson T; Robinson J
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):70-1; author reply 71-2. PubMed ID: 16441706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.